Abiopharma

New Form 8-K - ENSIGN GROUP, INC Filed: 2025-08-26 AccNo: 0001125376-25-000158 Size: 149 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

SI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025

Climer Crystal 🟡 adjusted position in 1.5K shares of Premier, Inc. (PINC) at $25.70 Transaction Date: Aug 22, 2025 | Filing ID: 000006

New Form 8-K - COGNITION THERAPEUTICS INC Filed: 2025-08-26 AccNo: 0001104659-25-083059 Size: 187 KB Item 8.01: Other Events

Director FOEHR MATTHEW W 🟢 acquired 540.5K shares of OmniAb, Inc. (OABI) at $1.85 Transaction Date: Aug 26, 2025 | Filing ID: 000009

Arcturus Therapeutics to Attend Upcoming Investor Conferences

Neurocrine Biosciences to Present at Upcoming Investor Conferences in September

New Form 6-K - SciSparc Ltd. Filed: 2025-08-26 AccNo: 0001213900-25-080737 Size: 12 KB

Altamira Therapeutics to Host First Half 2025 Financial Results and Business Update Call on August 29, 2025

Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences

BioXcel Therapeutics To Announce Topline Results from SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia on August 27, 2025

Cognition Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

Dolby Cinema vs IMAX: A 2025 Comparison of Premium Theater Experiences

The Latest on The Super Mario Bros. Movie 2: What We Know So Far

ASEN R SCOTT 🟢 acquired 5.9K shares of DURECT CORP (DRRX) at $1.92 Transaction Date: Aug 22, 2025 | Filing ID: 025520